News from vivus, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:VVUS)

Dec 29, 2015, 09:00 ET

A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss

 When it comes to New Year's weight loss resolutions and chronic weight management, the best laid plans don't always yield success. A new...

Apr 16, 2013, 14:30 ET

VIVUS Announces FDA Approval of Qsymia REMS Modification Allowing Access Through Certified Retail Pharmacies

 VIVUS, Inc. (Nasdaq: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved its amendment and modification to the...

Apr 10, 2013, 07:00 ET

New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting

A new educational program, Excess Weight and Your Health: A Guide to Effective, Healthy Weight Loss, developed by the Obesity Action Coalition...

Mar 25, 2013, 06:00 ET

Analysis In Health Economics Review Concludes Effective Medical Obesity Treatment Could Reduce Medicare Spending

 VIVUS, Inc. (Nasdaq:  VVUS) announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight...

Mar 07, 2013, 07:00 ET

VIVUS Launches Mobile App to Help Patients Lose Weight

 VIVUS, Inc. (Nasdaq: VVUS) announced today the launch of the Q and Me™ app, a no-cost mobile app available through iTunes and...

Mar 05, 2013, 07:00 ET

VIVUS Announces New Qsymia Offer

 VIVUS, Inc. (Nasdaq:  VVUS) today announced a new program offering eligible patients a discount on Qsymia® (phentermine and...

Feb 01, 2013, 07:00 ET

Study Concludes That Weight Loss With Qsymia™ Significantly Improves Multiple Cardiovascular Disease Risk Factors

VIVUS, Inc. (Nasdaq: VVUS) announced today the publication of a study concluding that weight loss resulting from treatment with QsymiaTM...

Dec 20, 2012, 06:30 ET

VIVUS Announces Express Scripts Adds Qsymia (Phentermine And Topiramate Extended-Release) Capsules CIV To Its Standard Benefits Program

 VIVUS, Inc. (NASDAQ: VVUS) today announced that Express Scripts, among the country's largest Pharmacy Benefit Managers (PBMs), has added...

Nov 12, 2012, 07:00 ET

Study Finds Significant Improvements In Patients With Obstructive Sleep Apnea Treated With Phentermine And Topiramate Extended-Release Capsules

 VIVUS, Inc. (NASDAQ: VVUS) today announced that a study published in the journal SLEEP (2012; 35(11):1529-1539) found that patients with...

Oct 17, 2012, 07:00 ET

VIVUS Submits REMS Amendment To FDA For Qsymia (Phentermine And Topiramate Extended-Release) Capsules CIV

 VIVUS, Inc. (NASDAQ: VVUS) today announced that it has submitted an amendment to the Risk Evaluation and Mitigation Strategy (REMS) for...

Oct 08, 2012, 07:00 ET

Express Scripts Joins Qsymia™ (Phentermine And Topiramate Extended-Release) Certified Home Delivery Pharmacy Network

 VIVUS, Inc. (NASDAQ: VVUS) today announced that Express Scripts, the country's largest Pharmacy Benefit Manager (PBM), has joined the...

Sep 20, 2012, 07:00 ET

VIVUS To Present New Data On Qsymia™ At 30th Annual Scientific Meeting of The Obesity Society

VIVUS, Inc. (Nasdaq:VVUS) today announced that multiple scientific abstracts will be presented at Obesity 2012, the 30th Annual Scientific Meeting...

Sep 18, 2012, 07:00 ET

VIVUS Announces Availability Of Once Daily Qsymia™ (Phentermine And Topiramate Extended-Release) Capsules CIV

 VIVUS, Inc. (NASDAQ: VVUS) today announced the U.S. market availability of Qsymia™ (pronounced Kyoo sim ee' uh). Qsymia is FDA-approved...

Jul 17, 2012, 21:14 ET

Vivus Announces FDA Approval of Once Daily Qsymia™ (Phentermine and Topiramate Extended-release) Capsules CIV

VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved Qsymia™ (pronounced Kyoo sim ee' uh)...

Apr 27, 2012, 15:41 ET

Vivus Announces FDA Approval Of STENDRA™ (avanafil) Tablets For The Treatment Of Erectile Dysfunction

VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the...

Feb 22, 2012, 17:55 ET

FDA Advisory Committee Recommends Approval of Qnexa®

 VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee...

Jan 17, 2012, 06:45 ET

REVIVE Trial Results for Avanafil Published in JSM Demonstrate Significant Improvement in Erectile Function

 VIVUS, Inc. (NASDAQ: VVUS) today announced that results from the REVIVE study were published in The Journal of Sexual Medicine (JSM), a...

Jan 09, 2012, 06:45 ET

VIVUS Provides Qnexa Regulatory Update

 VIVUS, Inc. (NASDAQ: VVUS) today announced that following recent discussions with Food and Drug Administration (FDA) officials, the company...

Jan 04, 2012, 06:45 ET

VIVUS to Present at the 2012 JP Morgan Healthcare Conference

VIVUS, Inc. (NASDAQ: VVUS) today announced that the Company will present at the 30th Annual JP Morgan Healthcare Conference. The VIVUS...

Dec 23, 2011, 06:45 ET

VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity

 VIVUS, Inc. (NASDAQ: VVUS) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and...